Literature DB >> 7075415

Progression of cimetidine-treated reflux esophagitis to a Barrett's stricture.

M Saltzman, K Barwick, R W McCallum.   

Abstract

A patient is described who developed a peptic stricture of the esophagus associated with Barrett's epithelium while receiving continuous cimetidine therapy. At this time, the role of cimetidine in the treatment of gastroesophageal reflux is evolving and, although it may provide symptomatic relief on some occasions, this report suggests that its role in improving the histological changes related to esophagitis or influencing complications of this disease has not been clarified.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7075415     DOI： 10.1007/bf01311715

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


  20 in total

1.  Improved infusion system for intraluminal esophageal manometry.

Authors:  R C Arndorfer; J J Stef; W J Dodds; J H Linehan; W J Hogan
Journal:  Gastroenterology       Date:  1977-07       Impact factor: 22.682

2.  Heartburn in pernicious anemia--a consequence of bile reflux.

Authors:  R C Orlando; E M Bozymski
Journal:  N Engl J Med       Date:  1973-09-06       Impact factor: 91.245

3.  Inhibition of gastric acid secretion by cimetidine in patients with duodenal ulcer.

Authors:  R M Henn; J I Isenberg; V Maxwell; R A Sturdevant
Journal:  N Engl J Med       Date:  1975-08-21       Impact factor: 91.245

4.  The "Barrett syndrome" (the columnar-lined lower oesophagus): an acquired condition secondary to reflux oesophagitis. A case report with discussion of pathogenesis.

Authors:  J F Halvorsen; B K Semb
Journal:  Acta Chir Scand       Date:  1975

5.  Effect of histamine and histamine antagonists on human lower esophageal sphincter function.

Authors:  J J Kravitz; W J Snape; S Cohen
Journal:  Gastroenterology       Date:  1978-02       Impact factor: 22.682

6.  Oral cimetidine in reflux esophagitis: a double blind controlled trial.

Authors:  E Wesdorp; J Bartelsman; K Pape; W Dekker; G N Tytgat
Journal:  Gastroenterology       Date:  1978-05       Impact factor: 22.682

7.  Barrett's ulcer and treatment with cimetidine.

Authors:  T Kothari; J C Mangla; T M Kalra
Journal:  Arch Intern Med       Date:  1980-04

8.  Cimetidine versus antacid in scleroderma with reflux esophagitis. A randomized double-blind controlled study.

Authors:  R J Petrokubi; G H Jeffries
Journal:  Gastroenterology       Date:  1979-10       Impact factor: 22.682

9.  Effect of cimetidine in symptomatic gastro-oesophageal reflux.

Authors:  P Powell-Jackson; H Barkley; T C Northfield
Journal:  Lancet       Date:  1978-11-18       Impact factor: 79.321

10.  Columnar-lined lower esophagus: an acquired lesion with malignant predisposition. Report on 140 cases of Barrett's esophagus with 12 adenocarcinomas.

Authors:  A P Naef; M Savary; L Ozzello
Journal:  J Thorac Cardiovasc Surg       Date:  1975-11       Impact factor: 5.209
View more
  3 in total

1.  Correlation between basal acid output and daily ranitidine dose required for therapy in Barrett's esophagus.

Authors:  M J Collen; D A Johnson
Journal:  Dig Dis Sci       Date:  1992-04       Impact factor: 3.199

Review 2.  Barrett's esophagus: pathogenesis, epidemiology, functional abnormalities, malignant degeneration, and surgical management.

Authors:  H J Stein; J R Siewert
Journal:  Dysphagia       Date:  1993       Impact factor: 3.438

3.  Elevated gastric acid secretion in patients with Barrett's metaplastic epithelium.

Authors:  M W Mulholland; B J Reid; D S Levine; C E Rubin
Journal:  Dig Dis Sci       Date:  1989-09       Impact factor: 3.199
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.